Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data ESG Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2022
FY2022
FY2023
FY2023
FY2023
FY2024
FY2025
Revenue
7.25
7.45
21.4
7.51
Cost of revenue
6.82
5.7
9.13
5.61
Gross profit
0.44
1.75
3.55
0.52
Research and development
1.01
0.61
0.71
0.36
Selling, general and administrative
1.35
1.15
2.4
General and administrative
0
0.05
0.56
0.04
1.35
Operating expenses
0
0.05
1.59
0.04
1.96
1.86
2.77
Operating income
-0
-0.05
-1.16
-0.04
-0.21
1.69
-2.25
Other non-operating income
0.13
-0.18
-0.44
-0.25
Pre-tax income
-0
-0.05
-1.02
-0.04
-0.39
1.25
-2.5
Income from continuing operations
1.69
-2.25
Net income to minority interests
-0.25
-0.07
0.3
-0.56
Net income
-0
-0.05
-0.77
-0.04
-0.32
0.94
-1.95
EBITDA
-0
-0.05
0.53
-0.04
1.25
3.45
-0.41
EPS, basic
0.00
-0.08
0.00
-0.02
0.04
-0.02
EPS, diluted
0.00
-0.08
0.00
-0.02
0.04
-0.02
Shares, basic (weighted)
15.5
25.9
15.5
25.9
25.9
25.9
Shares, diluted (weighted)
15.5
25.9
15.5
25.9
25.9
25.9
Balance sheet
FY2022
FY2022
FY2023
FY2023
FY2023
FY2024
FY2025
Cash and equivalents
0.13
0.09
0.14
0.01
0.34
0.11
0.04
Short-term investments
0.04
Receivables
0.06
0.04
Inventory
1.13
1.65
2.91
0.11
Other current assets
0.01
Total current assets
0.14
0.09
1.57
0.05
2.24
6.97
6.79
Property, plant and equipment
0
0
20.8
0
18.7
17.2
0
Intangible assets
3.25
3.09
2.93
2.99
Total assets
0.14
0.09
27.9
0.05
26.3
29.8
26.9
Accounts payable
0
1.23
0
1.3
4.6
0.08
Deferred revenue
1.57
1.36
Short-term debt
5.99
0.18
Total current liabilities
0
12.9
0
10.7
13.8
13.1
Long-term debt
1.1
1.14
Total liabilities
0
0
14.3
0
13.3
16
15.1
Total debt
1.42
1.25
1.14
Paid-in capital
0.12
0.12
11.2
0.12
11.2
11.2
11.2
Retained earnings
-0
-0.06
-0.9
-0.09
1.11
-0.17
-2.56
Other comprehensive income
-0.15
-0.43
-0.71
-0.31
Shareholders' equity
0.14
0.08
10.1
0.05
9.63
10.3
8.75
Minority interests
3.44
3.31
3.52
3.1
Total equity
0.14
0.08
13.7
0.05
12.9
13.8
11.9
Total liabilities and equity
0.14
0.09
27.9
0.05
26.3
29.8
26.9
Shares outstanding
15.5
15.5
25.9
15.5
25.9
25.9
25.9
Cash flow statement
FY2022
FY2022
FY2023
FY2023
FY2023
FY2024
FY2025
Net income
-0
-0.05
-1.02
-0.04
-0.39
1.25
-2.5
Depreciation and amortization
0
0
1.69
0
1.46
1.77
1.84
Deferred income tax
0.01
-0.67
0.01
-0.67
-0.52
-0.64
Change in inventory
-0.38
-0.52
-1.32
2.79
Change in payables
0
0.1
-0
0.22
3.42
-3.07
Cash from operations
-0.01
-0.04
0.12
-0.04
0.12
1.55
0.1
Capital expenditures
-0
-0.06
-0.69
-0.18
Purchases of investments
-0.04
Cash from investing
-0
-0.06
-0.04
-0.69
-0.18
Stock issued
0.14
Dividends paid
-2.15
-2.15
-2.15
Cash from financing
0.14
-0.15
-0.34
-1.03
0.89
Exchange rate effect
0.1
0.36
-0.01
-0.9
Net change in cash
0.13
-0.04
0.01
-0.08
0.14
-0.18
-0.09
Free cash flow
-0.04
0.06
0.86
-0.08
Interest paid
0.62
0.41
0.33
Income taxes paid
1.57
2.23
3.28
0.82
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.78 on November 9, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-1,574.0%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-64.9%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-85.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-233.3%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-111.9%
EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-306.1%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-150.0%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-93.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-108.9%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-15.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-9.6%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.34x
Current assets / current liabilities.
Quick ratio
0.29x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.29x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
$0.07
Cash from operations / diluted weighted shares.
Book value per share
-$0.02
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/OCF
27.5x
Market cap / cash from operations, when positive.
Earnings yield
-6.9%
Net income / market cap (the inverse of P/E).
What was ESG Inc.'s revenue in fiscal 2025?
ESG Inc. reported revenue of $7.5M for fiscal 2025, 64.9% lower than the year before.
Was ESG Inc. profitable in fiscal 2025?
No. It reported a net loss of $1.9M.
How much free cash flow did ESG Inc. generate in fiscal 2025?
Cash from operations of $101.2K minus capital expenditures of $178.2K left free cash flow of -$77.0K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.